The New York Times Agency May 2010
EN_00914465_9610
(NYT37) WASHINGTON -- March 18, 2005 -- DIABETES-DRUG -- Allen Andersson, owner of Paperboy Ventures, stands next to picture of a village that his company has built libraries on in Centeral America, in his Washington, DC, office, Friday, March 18, 2005. Andersson invested in Amylin in early 1999 when the company was facing collapse because the drug, Symlin, had failed to demonstrate statistically meaningful effects in two clinical trials. (Doug Mills/The New York Times)
CENA MINIMALNA - 100 USD
2005-03-18
EAST NEWS
The New York Times Agency
Doug Mills/The New York Times/Redux
16293411
0,77MB
25cm x 19cm przy 300dpi
18, 1999, 2005, A, ALLEN, AMERICA, AMYLIN, ANDERSSON, BECAUSE, BUILT, CENTERAL, CLINICAL, COLLAPSE, COMPANY, DC, DEMONSTRATE, DIABETES-DRUG, DOUG, DRUG, EARLY, EFFECTS, FACING, FAILED, FRIDAY, HAD, HAS, HIS, IN, INVESTED, LIBRARIES, MARCH, MEANINGFUL, MILLS, NEW, NEXT, NYT37, OF, OFFICE, ON, OWNER, PAPERBOY, PICTURE, REDUX, STANDS, STATISTICALLY, SYMLIN, THAT, THE, TIMES, TO, TRIALS, TWO, VENTURES, VILLAGE, WAS, WASHINGTON, WHEN, YORK,